AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

16.870

-0.880-4.96%

Volume:3.61M

Turnover:60.66M

Market Cap:5.71B

PE:126.17

High:17.740

Open:17.550

Low:16.480

Close:17.750

52wk High:18.320

52wk Low:8.260

Shares:338.72M

Float Shares:275.41M

Volume Ratio:1.13

T/O Rate:1.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.134

EPS(LYR):-0.030

ROE:7.36%

ROA:2.71%

PB:8.36

PE(LYR):-570.36

Loading ...

Overview Company News Filings

Telix's EPS Forecasts Rise Around 9% for Fiscal 2027, Around 21% for Fiscal 2028 After Glioma Drug Approval, Jefferies Says

MT Newswires Live

Australia's Telix Extends Gains After FDA Approval for Brain Cancer Imaging Drug

Telix Pharma CFO Darren Charlton Smith Acquires 2,071 Common Shares for AUD 19,999.58

FDA Approves Telix Brain Cancer Imaging Drug Pixclara for Glioma PET Scans

Telix Pharmaceuticals Limited-FDA Approves Telix Brain Cancer Imaging Drug Pixclara

THOMSON REUTERS

ASX Biggest Gainers

MT Newswires Live

Australia's Telix Pharma Gains on Completing Enrollment in Late-Stage Study

Telix Pharmaceuticals Completes Patient Enrollment in Phase Three Study of PSMA-PET Imaging Agents for Prostate Cancer Imaging

MT Newswires Live

Telix Completes Enrollment in Phase 3 Bipass Study, Aligns with FDA on Nda Pathway

THOMSON REUTERS

ASX Growth Companies With High Insider Ownership You Should Know

Simply Wall St.

Press Release: Telix Appoints David Gill as Chair

Telix Pharmaceuticals Limited-Telix Appoints David Gill as Chair

THOMSON REUTERS

Cochlear Stock And Two ASX Cash Flow Picks Trading Below Fair Value

Simply Wall St.

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.

Cash Flow Stocks Retail Investors May Be Missing In Australia

Simply Wall St.

Grand Pharma H1 FY26 Profit Attributable to Owners Falls 11.01% to Hk$1.06 Billion; Revenue Rises 3.2% to Hk$6.39 Billion

Telix Pharmaceuticals Stock Leads 3 ASX Picks Trading Below Cash Flow Value

Simply Wall St.

3 Fast Growing Australian Stocks With High Insider Ownership Worth Watching

Simply Wall St.

ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value

Simply Wall St.

WiseTech Global Stock And 2 Australian Shares Trading Below Cash Flow Value

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/TLX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":16.87,"timestamp":1789539120000,"preClose":17.75,"halted":0,"volume":3613622,"delay":0,"changeRate":-0.04957746478873234,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.13375681853238539,"marketStatus":"Not Yet Opened","change":-0.88,"latestTime":"09-16 16:12:00 AEST","open":17.55,"high":17.74,"low":16.48,"amount":60663956,"amplitude":0.070986,"askPrice":16.92,"askSize":2600,"bidPrice":16.85,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.13375681853238539,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":17.75,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":1.126262,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":17.75,"auctionPrice":16.87,"auctionVolume":284474,"auction":3,"marketStatus":"盘后竞价","timestamp":1789539016497}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.029578,"volumeRatio":1.126262,"shares":338721355,"dividePrice":0,"high":17.74,"amplitude":0.070986,"preClose":17.75,"low":16.48,"week52Low":8.26,"pbRate":"8.36","psRate":"4.58","week52High":18.32,"institutionHeld":0,"latestPrice":16.87,"committee":-0.677419,"eps":0.13371219342611387,"divideRate":0,"volume":3613622,"delay":0,"ttmEps":0.13371219342611387,"open":17.55,"prevYearClose":11.2,"prevWeekClose":15.67,"prevMonthClose":15.36,"prevQuarterClose":16.58,"fiveDayClose":16.69,"twentyDayClose":16.84,"sixtyDayClose":15.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667487616","title":"Telix's EPS Forecasts Rise Around 9% for Fiscal 2027, Around 21% for Fiscal 2028 After Glioma Drug Approval, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667487616","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667487616?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:31","pubTimestamp":1789450283,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  earnings per share  forecasts rose by around 9% in fiscal 2027 and around 21% in fiscal 2028 after securing US Food and Drug Administration  approval for its new drug application for Pixclara, according to a Monday note by Jefferies.Major changes to the forecasts include an assumption of US reimbursement approval and the beginning of material US sales from the start of fiscal 2027's second half.Pixclara is an amino acid positron emission tomography  drug for imaging glioma, a type of brain tumor.It is indicated for use with PET to differentiate recurrent or progressive glioma from treatment-related change, in conjunction with other diagnostic evaluations, in adults and paediatric patients one month of age and older.The brokerage assigned a buy rating to Telix with a raised price target of AU$30 per share from AU$29.30.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","PET.AU","TLX.AU","BK7047"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667961665","title":"Australia's Telix Extends Gains After FDA Approval for Brain Cancer Imaging Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667961665","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667961665?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:20","pubTimestamp":1789449641,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix extends gains after FDA approval for brain cancer imaging drug** Shares of Telix PharmaceuticalsTLX.AXextend gains into another day, rising as much as 11.5% to A$18.22, their hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691827","title":"Telix Pharma CFO Darren Charlton Smith Acquires 2,071 Common Shares for AUD 19,999.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691827","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691827?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:20","pubTimestamp":1789428051,"startTime":"0","endTime":"0","summary":"Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58Telix Pharmaceuticals: Group Chief Financial Officer Darren Charlton Smith increased his stake via a purchase of 2,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL487S5l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Telix Pharma CFO Darren Charlton Smith Acquires 2,071 Common Shares for AUD 19,999.58","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667633236","title":"FDA Approves Telix Brain Cancer Imaging Drug Pixclara for Glioma PET Scans","url":"https://stock-news.laohu8.com/highlight/detail?id=2667633236","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667633236?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:32","pubTimestamp":1789338774,"startTime":"0","endTime":"0","summary":"FDA approves Telix brain cancer imaging drug Pixclara for glioma PET scansFDA cleared Telix’s Pixclara, an F-18 PET imaging drug for glioma, marking the first approved FET-PET agent in the US.Label co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nNDLb2FtNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667633451","title":"Telix Pharmaceuticals Limited-FDA Approves Telix Brain Cancer Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667633451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667633451?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:21","pubTimestamp":1789338100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nTUE6SCT8Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664033823","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2664033823","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664033823?lang=en_us&edition=fundamental","pubTime":"2026-09-03 11:14","pubTimestamp":1788405296,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest gains on Thursday.Southgold 2 : +8%, AU$12.27Phylogica : +7%, AU$2.61OrezOne : +6%, AU$2.75Block : +5%, AU$113.81Telix Pharmaceuticals : +5%, AU$16.44Kingsgate Consolidated : +4%, AU$5.39Deep Yellow : +4%, AU$1.61Resolute Mining : +4%, AU$1.44Perseus Mining : +4%, AU$6.66Life360 : +4%, AU$19.92","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PYC.AU","BK7067","RSG.AU","BK7158","ORE.AU","BK4139","BK7506","BK7104","BK7016","BK7083","KCN.AU","SX2.AU","TLX","DYL.AU","360.AU","PRU.AU","TLX.AU","XYZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664389538","title":"Australia's Telix Pharma Gains on Completing Enrollment in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664389538","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664389538?lang=en_us&edition=fundamental","pubTime":"2026-09-02 12:04","pubTimestamp":1788321859,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix Pharma gains on completing enrollment in late-stage study** ASX-listed shares of Telix PharmaceuticalsTLX.AXrise 4.1% to A$15.89, on track for biggest one day pct gain since Aug","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U0BG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664867645","title":"Telix Pharmaceuticals Completes Patient Enrollment in Phase Three Study of PSMA-PET Imaging Agents for Prostate Cancer Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2664867645","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664867645?lang=en_us&edition=fundamental","pubTime":"2026-09-02 08:50","pubTimestamp":1788310213,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) completed patient enrollment in the phase three BiPASS study of its prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging agents Gozellix a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","TLX.AU","BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861070","title":"Telix Completes Enrollment in Phase 3 Bipass Study, Aligns with FDA on Nda Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861070?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:18","pubTimestamp":1788301129,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA3XXHQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664320861","title":"ASX Growth Companies With High Insider Ownership You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2664320861","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664320861?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:08","pubTimestamp":1788289704,"startTime":"0","endTime":"0","summary":"Amidst a backdrop of geopolitical tensions in the Middle East and fluctuating oil prices, the Australian market is experiencing volatility, with the S&P/ASX 200 expected to open lower following Wall Street's decline. In such uncertain times, identifying growth companies with high insider ownership can offer insights into potential resilience and confidence within those businesses.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SPL.AU","FRS.AU","XKO.AU","LTR.AU","STW.AU","AV1.AU","BK7067","QRE.AU","XAO.AU","BK7023","IIGF.AU","PDI.AU","QFN.AU","OZF.AU","AR1.AU","TLX","BK4139","VAP.AU","VAS.AU","BK7137","WZR.AU","IISV.AU","BEAR.AU","TTT.AU","XJO.AU","SLF.AU","OZR.AU","DACE.AU","EIGA.AU","EIQ.AU","BBOZ.AU","BK7508","BK7093","AWJ.AU","GIVE.AU","TLX.AU","BK7104","E200.AU","ZYAU.AU","BK7096","BK7501","GYG.AU","BK7036","IMLC.AU","BK7110","SKS.AU","BK7016","GEAR.AU","BK7504","IOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664688572","title":"Press Release: Telix Appoints David Gill as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2664688572","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664688572?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:21","pubTimestamp":1788214860,"startTime":"0","endTime":"0","summary":"-- David Gill appointed Chair of the Telix Board, effective immediately.-- Mr. Gill joined Telix as a Non-Executive Director in May 2026, with the. -- Dr. Mark Nelson will continue to serve on the Board as a Non-Executive","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4526","BK4585","BK4555","TLX.AU","BK7067","ASX","BK4543","BK4099","R","BK4588","BK4141","03160","BK4007","BK4604","BK4139","TLX","BK4232","TM","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885273","title":"Telix Pharmaceuticals Limited-Telix Appoints David Gill as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885273?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:18","pubTimestamp":1788214726,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUEC7TRSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663833045","title":"Cochlear Stock And Two ASX Cash Flow Picks Trading Below Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2663833045","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663833045?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:29","pubTimestamp":1788046160,"startTime":"0","endTime":"0","summary":"With central banks focused on inflation that has not meaningfully slowed, investors are paying closer attention to cash flows and valuation discipline. When policy makers keep rates in focus, solid cash generation can matter more than short term sentiment swings. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that combine discounted SWS DCF valuations with attractive cash flow potential for patient, value-oriented investors.\nThe three stocks in...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-stock-and-two-asx-cash-flow-picks-trading-below-fai","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-stock-and-two-asx-cash-flow-picks-trading-below-fai","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TACU","TLX.AU","BK4139","LYC.AU","BK4588","SPHQ","BK7095","BK7007","BK7507","BK7067","TSPA","CDIG","BK4585","TLX","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603266","title":"3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603266","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662603266?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:27","pubTimestamp":1787862425,"startTime":"0","endTime":"0","summary":"Global consumer confidence is starting to improve in places like Germany, Finland and Taiwan. That matters for growth focused companies that rely on people and businesses feeling comfortable enough to spend. When demand holds up, management teams often feel more confident about backing their own plans with personal capital. This article looks at three fast growing stocks with high insider ownership that fit that story today.\nThe three stocks below are just a starting sample, and the full...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XKO.AU","VAS.AU","IISV.AU","TLX","XJO.AU","OZR.AU","BEAR.AU","BK7095","BK4139","QFN.AU","OZF.AU","BBOZ.AU","XAO.AU","STW.AU","TLX.AU","E200.AU","SLF.AU","VAP.AU","IOZ.AU","IMLC.AU","GIVE.AU","LIN.AU","QRE.AU","GEAR.AU","DACE.AU","BK7067","EIGA.AU","PDI.AU","IIGF.AU","BK7104","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771276","title":"Cash Flow Stocks Retail Investors May Be Missing In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771276","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771276?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:25","pubTimestamp":1787808304,"startTime":"0","endTime":"0","summary":"Central banks in Europe are still signalling possible rate hikes to contain inflation. That keeps pressure on broad equity valuations and makes reliable cash generation more valuable. When investors worry about the path of rates, stocks with strong cash flow support and discounts to estimated fair value can look appealing. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that fit that profile.\nThe stocks covered below are just a small sample, and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/cash-flow-stocks-retail-investors-may-be-missing-in-australi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/cash-flow-stocks-retail-investors-may-be-missing-in-australi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","OZR.AU","MSB.AU","VAP.AU","GEAR.AU","SPHQ","EIGA.AU","ISBC","DACE.AU","BK4211","BBOZ.AU","TLX.AU","BK4588","IOZ.AU","SLF.AU","GIVE.AU","E200.AU","XJO.AU","BK7508","QRE.AU","IISV.AU","BK7501","QFN.AU","OZF.AU","XKO.AU","VAS.AU","BK7016","BK7503","WTC.AU","IMLC.AU","BK4139","IIGF.AU","BK4585","XAO.AU","STW.AU","BEAR.AU","TLX","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662271276","title":"Grand Pharma H1 FY26 Profit Attributable to Owners Falls 11.01% to Hk$1.06 Billion; Revenue Rises 3.2% to Hk$6.39 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662271276","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662271276?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:40","pubTimestamp":1787751612,"startTime":"0","endTime":"0","summary":"Grand Pharma H1 FY26 profit attributable to owners falls 11.01% to HK$1.06 billion; revenue rises 3.2% to HK$6.39 billionGrand Pharmaceutical Group reported first-half revenue of HK$6.39 billion, up 3.2% year over year.Profit attributable to owners fell 11% to HK$1.06 billion, with Telix fair-value and disposal gains of HK$88.78 million.Adjusted net operating profit attributable to owners, excluding Telix investment impacts, declined 6.63% to HK$972.76 million.Nuclear medicine anti-tumor diagnosis and treatment segment revenue jumped 55.4% to HK$655.24 million on higher clinical demand and new-product scaling.Pipeline updates included NMPA acceptance of TLX591-CDx NDA, NMPA commercialization clearance for TP-03, and FDA fast-track for GPN01530-2.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL3Fsrj5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","TLX.AU","BK1191","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662861786","title":"Telix Pharmaceuticals Stock Leads 3 ASX Picks Trading Below Cash Flow Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662861786","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662861786?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:41","pubTimestamp":1787632877,"startTime":"0","endTime":"0","summary":"With Germany’s 10 year Bund yields sitting near multi year highs as investors focus on inflation and tighter policy risk, a lot of attention has shifted back to dependable cash flows and what investors are paying for them. That sets the stage for mispriced opportunities where discounted cash flow values and market prices do not line up. This article highlights three undervalued cash flow stocks from the SWS DCF screener that may warrant a closer look.\nThe three stocks highlighted below are...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-leads-3-asx-picks-trading-below","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-leads-3-asx-picks-trading-below","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","TLX.AU","BK7095","BK7016","TLX","WTC.AU","BK4585","LYC.AU","SPHQ","BK7507","BK7503","BK4139","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662720056","title":"3 Fast Growing Australian Stocks With High Insider Ownership Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2662720056","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662720056?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:24","pubTimestamp":1787610259,"startTime":"0","endTime":"0","summary":"Euro Area consumer confidence just reached its strongest reading since February, even as investors watch energy and policy risks. When households feel more secure, companies with fast growth and high insider ownership can be well placed to turn that optimism into revenues and reinvestment. This article highlights 3 stocks from the Fast Growing Stocks With High Insider Ownership screener that align with this backdrop.\nThe three stocks covered below are just a sample, and the full screen...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/3-fast-growing-australian-stocks-with-high-insider-ownership-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/3-fast-growing-australian-stocks-with-high-insider-ownership-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BBOZ.AU","VAP.AU","TLX.AU","E200.AU","BEAR.AU","BK7508","DACE.AU","IISV.AU","BK7095","IIGF.AU","BK7501","XJO.AU","OZF.AU","TLX","LIN.AU","SLF.AU","BK4139","QFN.AU","STW.AU","ZYAU.AU","VAS.AU","GIVE.AU","OZR.AU","GEAR.AU","IMLC.AU","MSB.AU","XAO.AU","EIGA.AU","XKO.AU","QRE.AU","IOZ.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820966","title":"ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820966","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820966?lang=en_us&edition=fundamental","pubTime":"2026-08-25 03:04","pubTimestamp":1787598287,"startTime":"0","endTime":"0","summary":"As the Australian market looks to start the week on a positive note, buoyed by encouraging movements on Wall Street and a resilient commodities sector, investors are keenly observing opportunities for growth amidst fluctuating economic indicators like unemployment rates. In this environment, identifying stocks trading below their intrinsic value can offer potential advantages, as these investments may provide room for appreciation when market confidence is bolstered by favorable global and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/telecom/asx-slc/superloop-shares/news/asx-august-2026-stocks-estimated-to-be-trading-below-intrins","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/telecom/asx-slc/superloop-shares/news/asx-august-2026-stocks-estimated-to-be-trading-below-intrins","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RDY.AU","BK7016","BK4588","BK7104","SPHQ","ING.AU","BK4585","PNV.AU","BK7126","BK7084","BK4139","ARX.AU","BK7501","BK7094","SLC.AU","MSB.AU","CGS.AU","BK7055","BK7505","BGL.AU","TLX","BK7067","ELS.AU","TLX.AU","BK7508","BK7141","TEA.AU","BK7015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661241216","title":"WiseTech Global Stock And 2 Australian Shares Trading Below Cash Flow Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2661241216","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661241216?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:23","pubTimestamp":1787527420,"startTime":"0","endTime":"0","summary":"US services activity is growing at its strongest pace in nearly two years, which keeps cash rich companies in focus as investors watch how inflation and interest rate views evolve. When earnings quality matters more, stocks that generate solid cash flows yet trade below estimated fair value can attract fresh attention. This article looks at three stocks from the Undervalued Stocks Based On Cash Flows screener.\nThe stocks highlighted below are just a sample from this idea, with the full screen...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/wisetech-global-stock-and-2-australian-shares-trading-below-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/wisetech-global-stock-and-2-australian-shares-trading-below-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["OZR.AU","WTC.AU","E200.AU","BK7067","BK7503","TLX.AU","BK7016","BEAR.AU","EIGA.AU","IIGF.AU","XJO.AU","GIVE.AU","IMLC.AU","VAP.AU","IOZ.AU","BK7507","BBOZ.AU","DACE.AU","BK4588","OZF.AU","XKO.AU","QFN.AU","SPHQ","LYC.AU","ZYAU.AU","BK4585","SLF.AU","BK7095","XAO.AU","STW.AU","VAS.AU","QRE.AU","BK4139","GEAR.AU","TLX","IISV.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":198,"code":"91000000","status":"200"}]}}